Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension

NCT00945958 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: SPARC0913

Sponsor

Sun Pharma Advanced Research Company Limited